⌖ 22 Orbeli Bros. str., 0028 Yerevan, Armenia☎ +374 10 272247✉ info@physiol.sci.am
← All news and events
Dissertation defence

Study of the Physiological and Pharmacological Effects of MAO-Active Compounds in the Series of N-Containing Heterocycles

Results of studies in hypothalamic, amygdaloid complex, and liver homogenates։ In vitro studies demonstrated that compound 53c, a pyrido[1,2-a]pyrimidine derivative, exhibits concentration- and time-dependent monoamine oxidase (MAO)-inhibitory activity, affecting the deamination of serotonin, noradrenaline, dopamine, and phenylethylamine. Maximum inhibition of serotonin deamination (94–96%) was observed at a concentration of 1.0 μmol/mL after 30–60 minutes of incubation, exceeding the corresponding value for indopan (86%). At a concentration of 5.0 μmol/mL, an increase in enzymatic activity of 22–24% was also observed. Inhibition of noradrenaline deamination reached 76–84%, depending on the concentration and incubation time. Maximum inhibition of dopamine deamination was 72–74%, while that of phenylethylamine was approximately 40–50%. The most pronounced effect of the compound was observed on serotonin deamination.

Study of the Physiological and Pharmacological Effects of MAO-Active Compounds in the Series of N-Containing Heterocycles
Date12.12.2026 13:00
LocationOrbeli Institute of Physiology
Speaker / participantAnahit Grigoryan
Results of studies in hypothalamic, amygdaloid complex, and liver homogenates։ In vitro
studies demonstrated that compound 53c, a pyrido[1,2-a]pyrimidine derivative, exhibits
concentration- and time-dependent monoamine oxidase (MAO)-inhibitory activity, affecting the
deamination of serotonin, noradrenaline, dopamine, and phenylethylamine. Maximum inhibition
of serotonin deamination (94–96%) was observed at a concentration of 1.0 μmol/mL after 30–60
minutes of incubation, exceeding the corresponding value for indopan (86%). At a concentration
of 5.0 μmol/mL, an increase in enzymatic activity of 22–24% was also observed. Inhibition of
noradrenaline deamination reached 76–84%, depending on the concentration and incubation
time. Maximum inhibition of dopamine deamination was 72–74%, while that of
phenylethylamine was approximately 40–50%. The most pronounced effect of the compound
was observed on serotonin deamination.
Results of studies in the amygdaloid complex։ In amygdaloid complex homogenate, compound
53c inhibited the deamination of serotonin, noradrenaline, and dopamine. For serotonin and
dopamine, the most pronounced effect was observed mainly after 30–60 minutes of incubation,
whereas inhibition of noradrenaline deamination increased with longer incubation, reaching its
maximum after 90 minutes. The results indicate that the effect of the compound depends on the
substrate, concentration, and incubation time.
Results of studies in liver homogenate։ In liver homogenate, compound 53c affected the
oxidative deamination of serotonin, noradrenaline, dopamine, and phenylethylamine. According
to the results obtained, the magnitude of the MAO-inhibitory effect depended on the substrate,
concentration, and incubation time. These data confirm the effect of the compound on the
enzymatic system of liver tissue.
Effects of compound 53c in vivo։ In toxicity studies in rats, no signs of intoxication were detected
at the highest tested dose of compound 53c, 1250 mg/kg, whereas in mice, the median lethal dose
(LD50) was determined to be 780 mg/kg. In behavioral experiments, the effects of compound 53c
and the reference drug indopan differed depending on the substance administered and its dose. In
some cases, the combined administration of indopan with the substances under investigation was
associated with pronounced adverse effects and animal mortality. Following reserpine
administration, treatment with compound 53c was associated with signs of partial recovery of
body temperature and the animals’ general condition. In contrast, combined administration of
indopan resulted in marked deterioration of the animals’ condition and fatal outcomes. These
findings provide a basis for further investigation of the potential restorative and antidepressant
effects of compound 53c.
Investigation of psychotropic properties։ In the elevated plus maze test, administration of
compound 53c was associated with a decrease in the time spent in the closed arms and an increase
in the time spent in the open arms and central zone. In the forced swim test, the latency to the
first episode of immobility increased, the total duration of immobility decreased, and the duration
of active swimming increased. The observed changes are consistent with possible anxiolytic and
antidepressant activity of the compound; however, further statistical and experimental
confirmation is required.
Other biological properties of the compound։ The antioxidant effect of compound 53c was weak
and was detected only at the highest concentration tested. No antibacterial activity against the
microorganisms studied was detected. Structural comparisons suggesting possible sympatholytic
properties of the compound are of interest for further investigation; however, these properties
require direct experimental confirmation.
Neurophysiological and morphofunctional studies։ During high-frequency stimulation of the
cortical nucleus of the amygdaloid complex, the action of compound 53c was accompanied by
changes in the activity of neurons in the nucleus of the solitary tract (nucleus tractus solitarii,
NTS), which depended on the duration and frequency of stimulation. Administration of indopan
resulted in a more pronounced decrease in neuronal functional activity. According to the
morphofunctional studies, administration of compound 53c was not associated with pronounced
signs of structural damage to the neural structures examined, whereas morphological changes
were observed following indopan administration.
In conclusion, the results demonstrated that compound 53c exhibits MAO-inhibitory activity,
affects the deamination of various monoamines, and shows signs of possible anxiolytic and
antidepressant effects in behavioral models in animals. Under reserpine treatment, partial
recovery of body temperature and behavioral parameters was observed, while neurophysiological
experiments revealed changes in neuronal activity. The findings support considering compound
53c as a candidate for further pharmacological and preclinical studies. Additional targeted studies
are required to definitively assess its mechanisms of action, efficacy, and safety, taking into
account the severe adverse effects recorded in some experiments involving the combined
administration of substances.